Tag: Pharma
Lupin completes Phase 3 trials for Lucentis Biosimilar
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
USAID and Takeda launch Dengue prevention campaign
“हारेगा डेंगू, हराएंगे हम” campaign launched to spread awareness regarding dengue prevention and control
Budget 2024 reflects a forward-looking and inclusive approach: Anil Matai, DG,...
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) appreciated the positive strides yet also emphasized that the government could have announced incentives for pharma companies to develop medications for rare diseases
Pointblank & Systech Solutions INC partner to transform Indian healthcare with...
The collaboration aims to enhance patient care, streamline operations, and drive innovation in the Pharma and Healthcare sectors in India
CIPLA EU to invest an additional EUR 3 million in Ethris
This additional investment through a convertible loan will accelerate Cipla’s participation in the mRNA space
IPA to host 9th edition of Global Pharmaceutical Quality Summit
Two-day flagship event on 27-28 June 2024 in Mumbai; Top industry leaders expected to attend
Kotak Alt invests Rs 1445 crore to acquire API business of...
Post this acquisition, Matrix will be the 2nd largest Indian API player with global leadership in antiretroviral (ARV) APIs
India Unlimited: ICPA event in San Diego on 2nd June to...
Happening on the sidelines of US BIO 2024, the event will see top experts sharing their perspective on how international stakeholders can benefit from outsourcing their requirements to India
Indian pharma industry likely to reach US$ 130 billion by 2030:...
Need to add 30 lakh new hospital beds; aim to reach 100% health insurance coverage to achieve India’s healthcare vision 2047
ASPA calls for robust consumer awareness campaigns to combat counterfeiting in...
ASPA endeavors to inform consumers about common counterfeiting tactics and empower them to identify and avoid fraudulent products effectively.